The genus Physalis L. (Solanaceae) stands out for its remarkable biological diversity, encompassing more than 75 species used for both food and medicinal purposes. Physalis angulata L., an herbaceous plant widely distributed in tropical and subtropical regions, has been traditionally employed in folk medicine across several countries, including Brazil, Mexico, Peru, Indonesia, and China, where it is known as “Ku-Zhi” and used for treating dermatitis, tracheitis, malaria, rheumatism, and hepatitis. This study conducted a systematic literature review in indexed scientific databases (Scopus, Science Direct, and PubMed), identifying 799 articles, of which 32 were selected for detailed analysis. The reported pharmacological activities include antihyperglycemic, antileishmanial, anti-inflammatory, antifibrotic, antimicrobial, and immunomodulatory effects. Additionally, a patent survey was carried out in indexed databases (Espacenet, INPI, and LATIPAT), resulting in the selection of 28 patents, with the highest concentration in the A61K – Cosmetics category. This review highlights the bioactive metabolites isolated from P. angulata and their therapeutic properties demonstrated in in vitro and in vivo studies, while also assessing its technological potential through patent filings.